UCLA Gets $11.6M in NCI Funding for Prostate Cancer Program | GenomeWeb

NEW YORK (GenomeWeb News) – The University of California Los Angeles said today that its Jonsson Comprehensive Cancer Center (JCCC) and David Geffen School of Medicine have received $11.6 million from the National Cancer Institute to fuel a range of molecular research projects focused on prostate cancer.

The award continues providing funding for the center and the medical school to serve as a Specialized Program of Research Excellence (SPORE) for five years. It is the third grant they have received to fund this SPORE.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.